Variants of Amyotrophic lateral sclerosis and rehabilitation: an overview

被引:0
作者
Ilut, Silvina [1 ]
Stan, Adina [1 ]
Rahovan, Imelda [1 ]
Hapca, Elian [1 ]
Zmaranda, Ioana [1 ]
Strilciuc, Stefan [1 ]
Muresanu, Dafin F. [1 ]
机构
[1] Univ Med & Pharm Iuliu Hatieganu, Dept Neurosci, Cluj Napoca, Romania
来源
BALNEO AND PRM RESEARCH JOURNAL | 2023年 / 14卷 / 02期
关键词
amyotrophic lateral sclerosis; rehabilitation in ALS; flail leg; flail arm; progressive muscular atrophy; PROGRESSIVE MUSCULAR-ATROPHY; MOTOR-NEURON DISEASE; CLINICAL-FEATURES; FLAIL ARM; CORTICOSPINAL TRACT; PROGNOSTIC-FACTORS; NATURAL-HISTORY; DOUBLE-BLIND; ALS-PLUS; DIAGNOSIS;
D O I
10.12680/balneo.2023.559
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Amyotrophic lateral sclerosis (ALS) represents a progressive neurodegenerative disease that affects motor neurons in the brain and spinal cord leading to the impairment of voluntary muscle control and eventually death. It accounts for about 80%-90% of all motor neuron diseases, and is characterized by a marked variability in terms of clinical forms, genetics, survival rate and diagnostic particularities. A diagnosis of ALS or one of the variants comes with a great burden for the patient and patient's family because of the high morbidity and mortality rate of this disorder. As a consequence, it is mandatory to optimize the accuracy of the diagnostic process of ALS spectrum for providing the best clinical management and quality of life for patients and avoiding diagnostic mistakes. Our review focuses on the general and particular aspects of ALS and its variants in an effort to improve the process of diagnosis, therapy and exclusion of mimics of this group of diseases and to provide the latest findings in this field.
引用
收藏
页数:20
相关论文
共 89 条
[1]   Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial [J].
Abe, Koji ;
Aoki, Masashi ;
Tsuji, Shoji ;
Itoyama, Yasuto ;
Sobue, Gen ;
Togo, Masanori ;
Hamada, Chikuma ;
Tanaka, Masahiko ;
Akimoto, Makoto ;
Nakamura, Kazue ;
Takahashi, Fumihiro ;
Kondo, Kazuoki ;
Yoshino, Hiide .
LANCET NEUROLOGY, 2017, 16 (07) :505-512
[2]  
Adams RD, 2005, PRINCIPLES NEUROLOGY, V8th, P940
[3]   CSF and blood biomarkers in amyotrophic lateral sclerosis: protocol for a systematic review and meta-analysis [J].
Agah, Elmira ;
Saleh, Fatemeh ;
Moghaddam, Hossein Sanjari ;
Saghazadeh, Amene ;
Tafakhori, Abbas ;
Rezaei, Nima .
SYSTEMATIC REVIEWS, 2018, 7
[4]   Primary lateral sclerosis: Predicting functional outcome [J].
Almeida, Vania ;
de Carvalho, Mamede ;
Scotto, Manuel ;
Pinto, Susana ;
Pinto, Anabela ;
Ohana, Benjamim ;
Swash, Michael .
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2013, 14 (02) :141-145
[5]   Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis [J].
Andrews, Jinsy A. ;
Jackson, Carlayne E. ;
Heiman-Patterson, Terry D. ;
Bettica, Paolo ;
Brooks, Benjamin Rix ;
Pioro, Erik P. .
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2020, 21 (7-8) :509-518
[6]   Primary Lateral Sclerosis: Clinical, radiological and molecular features [J].
Bede, P. ;
Pradat, P-F ;
Lope, J. ;
Vourc'h, P. ;
Blasco, H. ;
Corcia, P. .
REVUE NEUROLOGIQUE, 2022, 178 (03) :196-205
[7]  
Belsh JM, 1999, NEUROLOGY, V53, pS26
[8]   A CONTROLLED TRIAL OF RILUZOLE IN AMYOTROPHIC-LATERAL-SCLEROSIS [J].
BENSIMON, G ;
LACOMBLEZ, L ;
MEININGER, V ;
BOUCHE, P ;
DELWAIDE, C ;
COURATIER, P ;
BLIN, O ;
VIADER, F ;
PEYROSTPAUL, H ;
DAVID, J ;
MALOTEAUX, JM ;
HUGON, J ;
LATERRE, EC ;
RASCOL, A ;
CLANET, M ;
VALLAT, JM ;
DUMAS, A ;
SERRATRICE, G ;
LECHEVALLIER, B ;
PEUCH, AJ ;
NGUYEN, T ;
SHU, C ;
BASTIEN, P ;
PAPILLON, C ;
DURRLEMAN, S ;
LOUVEL, E ;
GUILLET, P ;
LEDOUX, L ;
ORVOENFRIJA, E ;
DIB, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (09) :585-591
[9]   Edaravone: a new hope for deadly amyotrophic lateral sclerosis [J].
Bhandari, R. ;
Kuhad, A. ;
Kuhad, A. .
DRUGS OF TODAY, 2018, 54 (06) :349-360
[10]   Practical respiratory management in amyotrophic lateral sclerosis: evidence, controversies and recent advances [J].
Bourke, Stephen C. ;
Steer, John .
NEURODEGENERATIVE DISEASE MANAGEMENT, 2016, 6 (02) :147-160